0000950170-23-021769 Sample Contracts

CLEARSIDE BIOMEDICAL, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • May 12th, 2023 • Clearside Biomedical, Inc. • Pharmaceutical preparations • New York

Clearside Biomedical, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: